Global Drugs for Osteoarthritis Pain Market Research Report 2022

Global Drugs for Osteoarthritis Pain Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Drugs for Osteoarthritis Pain Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Osteoarthritis Pain Market Perspective (2017-2028)
2.2 Drugs for Osteoarthritis Pain Growth Trends by Region
2.2.1 Drugs for Osteoarthritis Pain Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Drugs for Osteoarthritis Pain Historic Market Size by Region (2017-2022)
2.2.3 Drugs for Osteoarthritis Pain Forecasted Market Size by Region (2023-2028)
2.3 Drugs for Osteoarthritis Pain Market Dynamics
2.3.1 Drugs for Osteoarthritis Pain Industry Trends
2.3.2 Drugs for Osteoarthritis Pain Market Drivers
2.3.3 Drugs for Osteoarthritis Pain Market Challenges
2.3.4 Drugs for Osteoarthritis Pain Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue
3.1.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue (2017-2022)
3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2017-2022)
3.2 Global Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Osteoarthritis Pain Revenue
3.4 Global Drugs for Osteoarthritis Pain Market Concentration Ratio
3.4.1 Global Drugs for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Osteoarthritis Pain Revenue in 2021
3.5 Drugs for Osteoarthritis Pain Key Players Head office and Area Served
3.6 Key Players Drugs for Osteoarthritis Pain Product Solution and Service
3.7 Date of Enter into Drugs for Osteoarthritis Pain Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Osteoarthritis Pain Breakdown Data by Type
4.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Type (2017-2022)
4.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2023-2028)
5 Drugs for Osteoarthritis Pain Breakdown Data by Application
5.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Application (2017-2022)
5.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Drugs for Osteoarthritis Pain Market Size (2017-2028)
6.2 North America Drugs for Osteoarthritis Pain Market Size by Country (2017-2022)
6.3 North America Drugs for Osteoarthritis Pain Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Drugs for Osteoarthritis Pain Market Size (2017-2028)
7.2 Europe Drugs for Osteoarthritis Pain Market Size by Country (2017-2022)
7.3 Europe Drugs for Osteoarthritis Pain Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size (2017-2028)
8.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Country (2017-2022)
8.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Drugs for Osteoarthritis Pain Market Size (2017-2028)
9.2 Latin America Drugs for Osteoarthritis Pain Market Size by Country (2017-2022)
9.3 Latin America Drugs for Osteoarthritis Pain Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Osteoarthritis Pain Market Size (2017-2028)
10.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2017-2022)
10.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Drugs for Osteoarthritis Pain Introduction
11.1.4 Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Introduction
11.2.4 Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Introduction
11.3.4 GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.3.5 GlaxoSmithKline Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Drugs for Osteoarthritis Pain Introduction
11.4.4 Bayer Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.4.5 Bayer Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Detail
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Introduction
11.5.4 Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.5.5 Eli Lilly Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Drugs for Osteoarthritis Pain Introduction
11.6.4 Novartis Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.6.5 Novartis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Drugs for Osteoarthritis Pain Introduction
11.7.4 Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.7.5 Sanofi Recent Development
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Detail
11.8.2 Horizon Pharma Business Overview
11.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Introduction
11.8.4 Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.8.5 Horizon Pharma Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Drugs for Osteoarthritis Pain Introduction
11.9.4 Abbott Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.9.5 Abbott Recent Development
11.10 Mylan
11.10.1 Mylan Company Detail
11.10.2 Mylan Business Overview
11.10.3 Mylan Drugs for Osteoarthritis Pain Introduction
11.10.4 Mylan Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.10.5 Mylan Recent Development
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Detail
11.11.2 Daiichi Sankyo Business Overview
11.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Introduction
11.11.4 Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.11.5 Daiichi Sankyo Recent Development
11.12 TEVA
11.12.1 TEVA Company Detail
11.12.2 TEVA Business Overview
11.12.3 TEVA Drugs for Osteoarthritis Pain Introduction
11.12.4 TEVA Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.12.5 TEVA Recent Development
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Detail
11.13.2 Almatica Pharma Business Overview
11.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Introduction
11.13.4 Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.13.5 Almatica Pharma Recent Development
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Detail
11.14.2 Astellas Pharma Business Overview
11.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Introduction
11.14.4 Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.14.5 Astellas Pharma Recent Development
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Detail
11.15.2 Tide Pharmaceutical Business Overview
11.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Introduction
11.15.4 Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.15.5 Tide Pharmaceutical Recent Development
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Detail
11.16.2 Iroko Pharmaceuticals Business Overview
11.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Introduction
11.16.4 Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.16.5 Iroko Pharmaceuticals Recent Development
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Detail
11.17.2 Hengrui Pharmaceutical Business Overview
11.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Introduction
11.17.4 Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.17.5 Hengrui Pharmaceutical Recent Development
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Detail
11.18.2 Abiogen Pharma Business Overview
11.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Introduction
11.18.4 Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022)
11.18.5 Abiogen Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of External
Table 5. Global Drugs for Osteoarthritis Pain Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Drugs for Osteoarthritis Pain Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Drugs for Osteoarthritis Pain Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Drugs for Osteoarthritis Pain Market Share by Region (2017-2022)
Table 9. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Drugs for Osteoarthritis Pain Market Share by Region (2023-2028)
Table 11. Drugs for Osteoarthritis Pain Market Trends
Table 12. Drugs for Osteoarthritis Pain Market Drivers
Table 13. Drugs for Osteoarthritis Pain Market Challenges
Table 14. Drugs for Osteoarthritis Pain Market Restraints
Table 15. Global Drugs for Osteoarthritis Pain Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Drugs for Osteoarthritis Pain Market Share by Players (2017-2022)
Table 17. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2021)
Table 18. Ranking of Global Top Drugs for Osteoarthritis Pain Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Drugs for Osteoarthritis Pain Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Drugs for Osteoarthritis Pain Product Solution and Service
Table 22. Date of Enter into Drugs for Osteoarthritis Pain Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drugs for Osteoarthritis Pain Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2017-2022)
Table 26. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2023-2028)
Table 28. Global Drugs for Osteoarthritis Pain Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2017-2022)
Table 30. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2023-2028)
Table 32. North America Drugs for Osteoarthritis Pain Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Drugs for Osteoarthritis Pain Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Drugs for Osteoarthritis Pain Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Drugs for Osteoarthritis Pain Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Drugs for Osteoarthritis Pain Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Drugs for Osteoarthritis Pain Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2023-2028) & (US$ Million)
Table 42. Pfizer Company Detail
Table 43. Pfizer Business Overview
Table 44. Pfizer Drugs for Osteoarthritis Pain Product
Table 45. Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 46. Pfizer Recent Development
Table 47. Johnson & Johnson Company Detail
Table 48. Johnson & Johnson Business Overview
Table 49. Johnson & Johnson Drugs for Osteoarthritis Pain Product
Table 50. Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 51. Johnson & Johnson Recent Development
Table 52. GlaxoSmithKline Company Detail
Table 53. GlaxoSmithKline Business Overview
Table 54. GlaxoSmithKline Drugs for Osteoarthritis Pain Product
Table 55. GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 56. GlaxoSmithKline Recent Development
Table 57. Bayer Company Detail
Table 58. Bayer Business Overview
Table 59. Bayer Drugs for Osteoarthritis Pain Product
Table 60. Bayer Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 61. Bayer Recent Development
Table 62. Eli Lilly Company Detail
Table 63. Eli Lilly Business Overview
Table 64. Eli Lilly Drugs for Osteoarthritis Pain Product
Table 65. Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 66. Eli Lilly Recent Development
Table 67. Novartis Company Detail
Table 68. Novartis Business Overview
Table 69. Novartis Drugs for Osteoarthritis Pain Product
Table 70. Novartis Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Sanofi Company Detail
Table 73. Sanofi Business Overview
Table 74. Sanofi Drugs for Osteoarthritis Pain Product
Table 75. Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Horizon Pharma Company Detail
Table 78. Horizon Pharma Business Overview
Table 79. Horizon Pharma Drugs for Osteoarthritis Pain Product
Table 80. Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 81. Horizon Pharma Recent Development
Table 82. Abbott Company Detail
Table 83. Abbott Business Overview
Table 84. Abbott Drugs for Osteoarthritis Pain Product
Table 85. Abbott Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 86. Abbott Recent Development
Table 87. Mylan Company Detail
Table 88. Mylan Business Overview
Table 89. Mylan Drugs for Osteoarthritis Pain Product
Table 90. Mylan Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 91. Mylan Recent Development
Table 92. Daiichi Sankyo Company Detail
Table 93. Daiichi Sankyo Business Overview
Table 94. Daiichi Sankyo Drugs for Osteoarthritis PainProduct
Table 95. Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 96. Daiichi Sankyo Recent Development
Table 97. TEVA Company Detail
Table 98. TEVA Business Overview
Table 99. TEVA Drugs for Osteoarthritis PainProduct
Table 100. TEVA Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 101. TEVA Recent Development
Table 102. Almatica Pharma Company Detail
Table 103. Almatica Pharma Business Overview
Table 104. Almatica Pharma Drugs for Osteoarthritis PainProduct
Table 105. Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 106. Almatica Pharma Recent Development
Table 107. Astellas Pharma Company Detail
Table 108. Astellas Pharma Business Overview
Table 109. Astellas Pharma Drugs for Osteoarthritis PainProduct
Table 110. Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 111. Astellas Pharma Recent Development
Table 112. Tide Pharmaceutical Company Detail
Table 113. Tide Pharmaceutical Business Overview
Table 114. Tide Pharmaceutical Drugs for Osteoarthritis PainProduct
Table 115. Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 116. Tide Pharmaceutical Recent Development
Table 117. Iroko Pharmaceuticals Company Detail
Table 118. Iroko Pharmaceuticals Business Overview
Table 119. Iroko Pharmaceuticals Drugs for Osteoarthritis PainProduct
Table 120. Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 121. Iroko Pharmaceuticals Recent Development
Table 122. Hengrui Pharmaceutical Company Detail
Table 123. Hengrui Pharmaceutical Business Overview
Table 124. Hengrui Pharmaceutical Drugs for Osteoarthritis PainProduct
Table 125. Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 126. Hengrui Pharmaceutical Recent Development
Table 127. Abiogen Pharma Company Detail
Table 128. Abiogen Pharma Business Overview
Table 129. Abiogen Pharma Drugs for Osteoarthritis PainProduct
Table 130. Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2017-2022) & (US$ Million)
Table 131. Abiogen Pharma Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Osteoarthritis Pain Market Share by Type: 2021 VS 2028
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. External Features
Figure 5. Global Drugs for Osteoarthritis Pain Market Share by Application in 2021 & 2028
Figure 6. Medical Care Case Studies
Figure 7. Personal Care Case Studies
Figure 8. Drugs for Osteoarthritis Pain Report Years Considered
Figure 9. Global Drugs for Osteoarthritis Pain Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Drugs for Osteoarthritis Pain Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Drugs for Osteoarthritis Pain Market Share by Region: 2021 VS 2028
Figure 12. Global Drugs for Osteoarthritis Pain Market Share by Players in 2021
Figure 13. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2021
Figure 15. North America Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Drugs for Osteoarthritis Pain Market Share by Country (2017-2028)
Figure 17. United States Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Drugs for Osteoarthritis Pain Market Share by Country (2017-2028)
Figure 21. Germany Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Drugs for Osteoarthritis Pain Market Share by Region (2017-2028)
Figure 29. China Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Drugs for Osteoarthritis Pain Market Share by Country (2017-2028)
Figure 37. Mexico Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Country (2017-2028)
Figure 41. Turkey Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Drugs for Osteoarthritis Pain Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Pfizer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 44. Johnson & Johnson Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 45. GlaxoSmithKline Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 46. Bayer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 47. Eli Lilly Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 48. Novartis Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 49. Sanofi Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 50. Horizon Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 51. Abbott Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 52. Mylan Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 53. Daiichi Sankyo Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 54. TEVA Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 55. Almatica Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 56. Astellas Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 57. Tide Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 58. Iroko Pharmaceuticals Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 59. Hengrui Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 60. Abiogen Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs